Merck Profile

60.99
USD 0.29  0.47%
61%
51%

Exercise or conversion by Adam Schechter of 2083 shares of Merck subject to Rule 16b-3

Merck Co insider trading alert for exercise of common stock - dividend reinvestment by Adam Schechter, President USHH, on June 20, 2018. This event was filed by Merck Co Inc with SEC on 2007-03-01. Statement of changes in beneficial ownership - SEC Form 4. Adam Schechter is currently serves as president of global human health and executive vp of Merck Co [view details]   

Merck Summary

Being in one of the most regulated sectors, Merck is one of the names in big pharma and distributes many different types of medications and drugs. This industry is a go big or go home industry as that research and development costs large sums of money to complete, and if they drug does not get FDA approval, all of that work was for not. Also, it is important to keep an eye on the medical marijuana market as this is a direct threat to companies that produce medications. [more]
Merck Co (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 69,000 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 164.86 B. Merck Co runs under Healthcare sector within Pharmaceuticals And Biosciences industry. This company has 2.69 B outstanding shares of which 18.21 M shares are now shorted by investors with about 1.9 days to cover shorted positions. MERCK CO INC has about 7.35 B in cash with 6.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73.
Check Merck Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 60.99HorizonTargetOdds Above 60.99
55.67%30 days 60.99 43.88%
Based on normal probability distribution, the odds of Merck to move above current price in 30 days from now is about 43.88% (This Merck Co probability density function shows the probability of Merck Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares199 M10.8 B
Blackrock IncCommon Shares184.7 M10.1 B
View Merck Diagnostics

Selected Merck Co Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Revenues    

Key Fundamentals

Merck Against Markets

Risk Adjusted
Performance Score (0 to 100)
13 
Chance of
Financial Distress (0 to 100%)
14 
Equity ratings for Merck Co are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
It operates in four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange. It employs 69000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameMerck Co
Chairman, CEO and PresKenneth FrazierView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
LocationNEW JERSEY, U.S.A
Business Address2000 Galloping Hill Road
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number00310158.0
ISINUS58933Y1055
CUSIP58933Y105
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.merck.com
Contact Number908 740 4000
Related EntitySGP
CurrencyUSD - US Dollar

Recommendations

Merck Analyst Recommendations
Target PriceAdvice# of Analysts
67.73Buy11Odds
Merck Co current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Merck Analyst Advice  

Merck Dividends

Upcoming distributions to stockholders

Earnings

Merck Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.82May 2, 2017
Merck Co normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Merck Corporate Directors
Thomas Glocer Independent Director
Craig Thompson Independent Director
Rochelle Lazarus Independent Director
Please see also Stocks Correlation. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.